USPTO serial 79433946
G.FEEL
Reviewed by CopyMark Law Group
Status 661
- Filing date
- Status date
- Registration date
- —
- Examiner
- DUONG, ANGELA GAW
- Law office
- TMO LAW OFFICE 130
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with G.FEEL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Aloe vera preparations for pharmaceutical purposes; amino acids for medical purposes; food supplements, namely, antioxidant pills; antiparasitic preparations; appetite suppressants for medical purposes; appetite suppressant pills; plant extracts, other than essential oils, for pharmaceutical purposes; bacterial preparations for medical and veterinary use; food supplements, namely, albuminous foodstuffs for medical purposes for human and animal use; protein dietary supplements; albuminous preparations for medical purposes, namely, albumin dietary supplements, albuminous specialized medical foods designed for patients with specific dietary or nutritional deficiencies; balms for medical purposes; balsamic preparations for medical purposes; biological preparations for medical purposes, namely for improvement of human general well-being and eliminating of fatigue syndrome; chemical preparations for pharmaceutical purposes, namely, for improvement of the patient's human general well-being and eliminating of fatigue syndrome, normalizing of haemoglobin levels, eliminating of peripheral oedema of the lower limbs, normalizing of the body mass index, relief of post-COVID syndrome, headache relief and treatment of dehydration; chemical preparations for medical purposes, namely, for normalizing of haemoglobin levels, eliminating of peripheral oedema of the lower limbs, normalizing of the body mass index, relief of post-COVID syndrome, headache relief and treatment of dehydration; oxygen baths for medical use; dermatological preparations; mineral, sodium, potassium and magnesium salts for medical purposes; douching preparations for medical purposes; pharmaceutical preparations, namely, elixirs for improvement of the patient's human general well-being and eliminating of fatigue syndrome; ethers for pharmaceutical purposes; eucalyptus for pharmaceutical purposes; eucalyptol for pharmaceutical purposes; pharmaceutical preparations for treating sunburn; pharmaceutical preparations for normalizing of haemoglobin levels, eliminating of peripheral oedema of the lower limbs, normalizing of the body mass index, relief of post-COVID syndrome, headache relief and treatment of dehydration; ferments for pharmaceutical purposes; enzymes for medical purposes; enzyme preparations for medical purposes; enzyme dietary supplements; phytotherapy preparations for medical purposes; glucose for medical purposes; glucose dietary supplements; medicinal oils, other than essential oils; medicinal drinks; therapeutic preparations for the bath, namely, bath salts for medical purposes, medicinal oils or herbal infusions for baths, medicated bath preparation; nutritional supplement, namely, haematogen; homogenized food adapted for medical purposes; hormones for medical purposes; immunostimulants; personal sexual lubricants; isotopes for medical purposes; whey protein dietary supplements; by-products of the processing of cereals for dietetic or medical purposes; sea water for medicinal bathing; cachets for pharmaceutical purposes in the nature of capsule, wafer, or shell; gelatin and vegetable capsules for medicines; casein dietary supplements; collagen for medical purposes; dietary supplements with a cosmetic effect; wheat germ dietary supplements; slimming pills; medical preparations for slimming purposes; freeze-dried food adapted for medical purposes; adhesive plasters for medical purposes; adhesive tapes for medical purposes; pharmaceutical preparations for reducing sexual activity; magnesia for pharmaceutical purposes; massage gels for medical purposes; massage candles for therapeutic purposes; honey-based ointment for medical purposes; menthol, namely, menthol for pharmaceutical purposes; yeast dietary supplements; almond oil for medical purposes; almond milk for pharmaceutical purposes; soporifics; mineral supplements, namely, preparations of trace elements for human and animal use; mineral dietary supplements; mineral water salts for medical purposes; medicated salts for mineral water baths; mineral waters for medical purposes; nutritional supplements; sodium salts for medical purposes; medicinal herbs, namely, nervines; herbal teas for medicinal purposes, namely, decoctions for pharmaceutical purposes; adjuvants for medical purposes; pastilles for pharmaceutical purposes; pearl powder for medical purposes; headache relief sticks; sticking plasters for medical use; medicinal mud for baths; sexual stimulant gels; skin serums for medical purposes; syrups for pharmaceutical purposes for improvement of human general well-being and eliminating of fatigue syndrome; inhalants for medical purposes, namely, cough treatment inhalants; fumigating sticks as disinfectants; fumigating pastilles as disinfectants; steroids; pharmaceutical preparations, namely, tonics for improvement of the patient's human general well-being and eliminating of fatigue syndrome; linseed for pharmaceutical purposes, namely, linseed oil dietary supplements, linseed dietary supplements, linseed meal for pharmaceutical purposes; lozenges for pharmaceutical purposes, namely, cough lozenges; ointments for pharmaceutical purposes, namely, antibiotic ointments, anti-inflammatory ointments; pomades for medical purposes; sunburn ointments; thermal water, namely, therapeutic preparations for baths or medicinal bathing; tinctures for medical purposes, namely, herbal tinctures; smelling salts; pharmaceutical preparations for normalizing of haemoglobin levels, eliminating of peripheral oedema of the lower limbs, normalizing of the body mass index, relief of post-COVID syndrome, headache relief and treatment of dehydration; drugs for medical purposes for improvement of the patient's human general well-being and eliminating of fatigue syndrome; medicines for veterinary purposes, namely antibiotics and vaccines, parasiticides, healing ointments, skin sprays, antiseptic washes, and ear drops; medicines for human purposes for normalizing of haemoglobin levels, eliminating of peripheral oedema of the lower limbs, normalizing of the body mass index, relief of post-COVID syndrome, headache relief and treatment of dehydration; anti-inflammatories; medicines for alleviating constipation; medicinal herbs; medicinal hair growth preparations; medicated sweets for the treatment of throat irritation, coughing, or sore throat; cotton sticks for medical purposes; cotton swabs for medical purposes; petroleum jelly for medical purposes; purgatives; depuratives for the body; digestives for pharmaceutical purposes; vitamin supplement patches; vitamin preparations; bath tea for therapeutic purposes; bath salts for medical purposes; bath preparations for medical purposes; cooling sprays for medical purposes; caustics for pharmaceutical purposes; food supplements, namely, gelatine for medical purposes; pollen dietary supplements; dietary supplements for human beings; herbal teas for medicinal purposes; herbal extracts, other than essential oils, for medical purposes; cod liver oil; suppositories in the nature of finished rectal, vaginal, or urethral suppositories | ACTIVE | — |
| 032 | Aerated water; preparations for making aerated water, namely, essences, and extracts used to make soft drinks and carbonated table waters; vegetable juices; energy drinks; non-alcoholic essences for making non-alcoholic beverages; aloe vera drinks, non-alcoholic; aperitifs, non-alcoholic; non-alcoholic beverages flavoured with tea; non-alcoholic dried fruit beverages; non-alcoholic beverages, namely, non-alcoholic beverages flavoured with coffee, cocktails, non-alcoholic, non-alcoholic honey-based beverages; non-alcoholic fruit extracts used in the preparation of beverages; fruit nectars, non-alcoholic; non-alcoholic fruit juice beverages; powders for making soft drinks; preparations for making non-alcoholic carbonated, fruit juice, fruit flavored beverages; carbonated water; preparations for making non-alcoholic carbonated water; preparations for making non-alcoholic carbonated beverages, namely, powders for effervescing beverages; preparations for making non-alcoholic carbonated beverages, namely, pastilles for effervescing beverages; table waters; isotonic beverages; whey beverages; lemonades; mineral water; soft drinks; syrups for making non-alcoholic fruit juice, vegetable juice beverages; syrups for lemonade; soda water; protein-enriched sports beverages; smoothies; fruit juices; waters, namely, flavored water, carbonated water; grape must, unfermented; sherbet beverages | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 5, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 5, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 5, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 26, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 6, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 6, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 12, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 11, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 17, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 17, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 3, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 6, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 6, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 2, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |